ArticleFrontiers in endocrinology2024

Glucagon-like peptide-1 receptor agonists and the risk of erectile dysfunction: a drug target Mendelian randomization study.

Hongjin An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.